Discover the Power of NovaMatrix® UltraPure Alginates
Deep dive into a world of ultrapure biopolymers!
NovaMatrix®, is powered by IFF Pharma Solutions unrivaled polymer design capabilities and global manufacturing footprint to bring ultrapure biopolymers and custom solutions to the biopharmaceutical and medical device industries.
Delivering befitting solutions via a well-characterized product portfolio
NovaMatrix®:Deep expertise, polymer science know-how to advance medical innovations.
NovaMatrix®
Deep expertise, polymer science know-how to advance medical innovations.
For us, sustainability isn’t just a responsible approach, it is innovation itself. That’s why we are constantly creating processes and tools to minimize and measure carbon footprint and to create products from waste streams.
From sourcing ingredients to process efficiency and waste upcycling, we’re ahead of the game. Our application of enzyme technology is a genuine game-changer, and fast becoming an essential tool to drive sustainability metrics.
Meet PRONOVA® UltraPure alginates, a range of versatile, safe, and bio-compatible marine biopolymers. They are purified for biomedical and pharmaceutical applications and have been used for commercial medical applications for over two decades now.
Key Properties
Biocompatible
Ultrapure, for medical use
Hydrogel formation in presence of divalent cations
Gelation at constant temperature
Controllable rheology and gelation
Cold / hot water solubility
Long shelf life: 3-5 years depending on product
Introducing NOVATACH™ peptide-coupled alginates that promote interactions between cells and alginate-based scaffolds, opening a plethora of development opportunities in cell immobilization, 3D bio-printing, tissue design, and much more.
Key Properties
Biocompatible and naturally-occurring
Sterile filtered and lyophilized
High affinity for adherent cells
Customizable peptide sequences
Improves cell adhesion
Controllable rheology and gelation
Cold / hot water solubility
NovaMatrix® sodium hyaluronate are manufactured using Streptococcus Zooepidemicus in a fermentation process, yielding a highly purified, well-characterized biopolymer for use in biomedical, cosmetic, and pharmaceutical applications
Key Properties
Non-animal origin
Highly purified, low-endotoxins
Designed pharmaceutical and medical applications
Forms highly viscous aqueous solutions
Large product line offering to meet a wide renage of applications
Commitment to Manufacturing Excellence
NovaMatrix® from IFF Pharma Solutions delivers ultrapure biopolymers that are safe, established, and valuable for customers across the pharmaceutical, biotechnology and biomedical industries.
Our NovaMatrix® facility near Oslo, Norway is cGMP, ISO9001 and ISO13485 qualified to ensure quality, reliability, and safety.
We hold an API manufacturing license and our ultrapure sodium alginate is described in a Drug Master File with the US Food & Drug administration.
Book a Chat With Us
Our IFF NovaMatrix® experts are working tirelessly, to define the ‘Future of Biotechnology’.
Discover how we are leading the biologics space as a producer of ultrapure biopolymers for applications such as drug delivery, tissue engineering, cell encapsulation, and medical devices.
Register here to talk to an expert.
